Insulin Aspart: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Insulin Aspart. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Hypoglycemia | 76% |
| Headache | 35% |
| Influenza-like symptoms | 13% |
| Rhinitis | 12% |
| Dyspepsia | 9% |
| Neuropathy | 8% |
| Back pain | 7% |
| Diarrhea | 7% |
| Pharyngitis | 7% |
| Skeletal pain | 5% |
| Infection | 5% |
| Abdominal pain | 5% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
NovoLog Mix 70/30 is an insulin analog indicated to improve glycemic control in patients with diabetes mellitus. Important Limitations of Use: In premix insulins, such as Novolog Mix 70/30, the proportions of rapid acting and long acting insulins are fixed and do not allow for basal versus prandial dose adjustments.
Source: FDA labeling via NIH DailyMed (set 973a9333…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.